These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35546087)

  • 1. Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series.
    Béchard L; Morasse-Bégis M; Corbeil O; Hakim JR; Malenfant E; Brodeur S; Huot-Lavoie M; Essiambre AM; Demers MF; Roy MA
    J Clin Psychopharmacol; 2022 Jul-Aug 01; 42(4):391-395. PubMed ID: 35546087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
    Béchard L; Corbeil O; Plante M; Thivierge MA; Lafrenière CÉ; Roy MA; Demers MF
    J Psychopharmacol; 2021 Sep; 35(9):1152-1157. PubMed ID: 34229529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review.
    Corbeil O; Béchard L; Fournier É; Plante M; Thivierge MA; Lafrenière CÉ; Huot-Lavoie M; Brodeur S; Essiambre AM; Roy MA; Demers MF
    J Psychopharmacol; 2023 Apr; 37(4):370-377. PubMed ID: 36794520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N; Myles H; Clark SR; Bird R; Siskind D
    Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
    Lally J; Malik S; Krivoy A; Whiskey E; Taylor DM; Gaughran FP; Flanagan RJ; Mijovic A; MacCabe JH
    J Clin Psychopharmacol; 2017 Oct; 37(5):600-604. PubMed ID: 28817489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
    Manu P; Lapitskaya Y; Shaikh A; Nielsen J
    Am J Ther; 2018; 25(2):e218-e223. PubMed ID: 29505490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW; Bogers JP; Giltay EJ
    Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
    J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium and clozapine rechallenge: a retrospective case analysis.
    Kanaan RA; Kerwin RW
    J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine re-challenge under the cover of Filgrastim.
    Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
    J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E; Taylor D
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.
    Manu P; Sarpal D; Muir O; Kane JM; Correll CU
    Schizophr Res; 2012 Feb; 134(2-3):180-6. PubMed ID: 22113154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As-Required Filgrastim for Late-Onset Neutropenia Complicating Long-Term Clozapine Treatment: a Case Report.
    Chan KSW; Lai NBW; Wong MMC; Pang PF
    East Asian Arch Psychiatry; 2023 Mar; 33(1):28-31. PubMed ID: 36991553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.
    Remington G; Lee J; Agid O; Takeuchi H; Foussias G; Hahn M; Fervaha G; Burton L; Powell V
    Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.
    Silva E; Higgins M; Hammer B; Stephenson P
    BMC Psychiatry; 2020 Jun; 20(1):279. PubMed ID: 32503471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
    Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.
    Dunk LR; Annan LJ; Andrews CD
    Br J Psychiatry; 2006 Mar; 188():255-63. PubMed ID: 16507968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.